Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home
- Monday, September 12, 2022, 7:04
- Finance
- Add a comment
TORONTO, Sept. 12, 2022 /PRNewswire/ – Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”) (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related…
About the Author
adminasapcorp has written 42197 stories on this site.